Gabriele Cerrone

Gabriele Marco Antonio Cerrone is the founder of Tiziana Life Sciences Ltd. (United Kingdom) founded in 1998, holding the titles of Executive Chairman & Chief Executive Officer and Executive Chairman since 2024.
Founder of Cardiff Oncology, Inc. founded in 1999, served as Co-Chairman in 2006.
Founder of FermaVir Pharmaceuticals LLC founded in 2004, served as Chairman from 2004 to 2007.
Founder of Synergy Pharmaceuticals LLC founded in 2008, served as Chairman.
Founder of Rasna Therapeutics, Inc. founded in 2013, served as Chairman.
Founder of AccuStem Sciences, Inc. founded in 2020, serving as Non-Executive Chairman since 2021.
Mr. Cerrone is also the founder of Hepion Pharmaceuticals, Inc.,Arna Therapeutics Ltd.,Biovitas Capital Ltd.,Gensignia Life Sciences, Inc.,Gensignia Ltd...
Current positions include Executive Chairman & Managing Partner at Panetta Partners Ltd. since 2013, Non-Executive Chairman at OKYO Pharma Ltd. since 2021, and Director at Gensignia IP Ltd. since 2014.
Former positions include Chairman at Callisto Pharmaceuticals, Inc. from 2003 to 2013, Director at SIGA Technologies, Inc. in 2003, Independent Director at Inhibitex LLC from 2011 to 2012, Director at Pawfect Foods, Inc., Managing Director-Investments at Barrington Capital Group LP in 1999, and Senior Vice President-Investments at Oppenheimer & Co., Inc. from 1999 to 2005.
Education includes an MBA from The Leonard N Stern School of Business.